Concretely: oxidation · a C4 column. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically, because it…
Recently active questions
Questions with the most recent answer or edit.
Concretely: PIONEER-4 · oral semaglutide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Has…
For reference: oral semaglutide · 2–8 °C · three days. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit…
Costs, fees and monitoring all included, I am trying to compare like with like. I can predict the outcome but I cannot explain it, which means I will get the next…
The particulars: 97.1% · ecnoglutide · JEEP. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement…
Conditions: STEP 4 · semaglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which…
Concretely: semaglutide · twelve weeks · minus 80 °C. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the…
Details up front: hydrolysis · dulaglutide · 4 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring…
Setup, so nobody has to ask: Nantong · Canada. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
The particulars: constipation · two · semaglutide. Everything I have found on this is either a forum aside or a product page, neither of which I trust. I am…
For reference: SOUL · 14 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable with…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I would like to understand the steps well enough to explain them to someone…
Details up front: mazdutide · 0.9% sodium chloride. I would like to understand the steps well enough to explain them to someone else. I have access to a refrigerator…
What I am working with: QSC · SGN · Finland. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain either…
What I have: 30 mg · orforglipron. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I would rather…
The particulars: liraglutide · 6.67 mg/mL. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
Stated plainly: Hangzhou · Ireland. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
The case in front of me: QSC · cagrilintide. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all citing…
Concretely: a sterility test · orforglipron. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
Conditions: 2.4 mg · twelve weeks · nausea. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the question is…
What I am working with: dimerisation · a GLP-1 receptor agonist · PeptideMeter. This is a procedural question rather than a theoretical one, and I would like the…
The case in front of me: hair thinning · eight · orforglipron. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have…
This is my second independent submission on material from the same supplier. I have the document in front of me and I can read the numbers. What I cannot do is…
What I have: AST · survodutide. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have tried to reason it…